Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2017, Article ID 6140896, 7 pages
https://doi.org/10.1155/2017/6140896
Research Article

Plasmatic Soluble Receptor for Advanced Glycation End Products as a New Oxidative Stress Biomarker in Patients with Prosthetic-Joint-Associated Infections?

1Department of Biomedical, Surgical and Dental Sciences, Università degli Studi di Milano, Milan, Italy
2Department of Biomedical Sciences for Health, Università degli Studi di Milano, Milan, Italy
3IRCCS Galeazzi Orthopaedic Institute, Milan, Italy
4U.O.C SMEL-1 Patologia Clinica IRCCS Policlinico San Donato, San Donato, Milan, Italy
5Department of Food, Environmental and Nutritional Sciences (DeFENS), Università degli Studi di Milano, Milan, Italy
6Department of Medical Biotechnology and Translational Medicine, Università degli Studi di Milano, Milan, Italy
7Department of Health Sciences, Università degli Studi di Milano, Milan, Italy

Correspondence should be addressed to Emanuela Galliera; ti.iminu@areillag.aleuname

Received 7 July 2017; Revised 28 September 2017; Accepted 25 October 2017; Published 13 December 2017

Academic Editor: Benoit Dugue

Copyright © 2017 Luca Massaccesi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. W. Bauer, J. Parvizi, N. Kobayashi, and V. Krebs, “Diagnosis of periprosthetic infection,” The Journal of Bone & Joint Surgery. American Volume, vol. 88, no. 4, pp. 869–882, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Parvizi, E. Ghanem, S. Menashe, R. L. Barrack, and T. W. Bauer, “Periprosthetic infection: what are the diagnostic challenges?” The Journal of Bone & Joint Surgery-American Volume, vol. 88, Supplement 4, pp. 138–147, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Drago, C. Vassena, E. Dozio et al., “Procalcitonin, C-reactive protein, interleukin-6, and soluble intercellular adhesion molecule-1 as markers of postoperative orthopaedic joint prosthesis infections,” International Journal of Immunopathology and Pharmacology, vol. 24, no. 2, pp. 433–440, 2011. View at Publisher · View at Google Scholar
  4. M. M. Tunney, S. Patrick, S. P. Gorman et al., “Improved detection of infection in hip replacements. A currently underestimated problem,” The Bone & Joint Journal, vol. 80, no. 4, pp. 568–572, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Parvizi, L. Walinchus, and B. Adeli, “Molecular diagnostics in periprosthetic joint infection,” The International Journal of Artificial Organs, vol. 34, no. 9, pp. 847–855, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. E. Galliera, E. Dozio, G. Dogliotti et al., “Iron status evaluation as a marker of postoperative joint infection: a pilot study,” International Journal of Immunopathology and Pharmacology, vol. 25, no. 4, pp. 1149–1155, 2012. View at Publisher · View at Google Scholar
  7. E. Galliera, L. Drago, M. G. Marazzi, C. Romano, C. Vassena, and M. M. Corsi Romanelli, “Soluble urokinase-type plasminogen activator receptor (suPAR) as new biomarker of the prosthetic joint infection: correlation with inflammatory cytokines,” Clinica Chimica Acta, vol. 441, pp. 23–28, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. E. Galliera, L. Drago, C. Vassena et al., “Toll-like receptor 2 in serum: a potential diagnostic marker of prosthetic joint infection?” Journal of Clinical Microbiology, vol. 52, no. 2, pp. 620–623, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. A. A. Hagag, S. M. Amin, R. B. El-Fiky, and M. E. El-Sayad, “Study of serum levels of some oxidative stress markers in children with Helicobacter pylori infection,” Infectious Disorder Drug Targets, vol. 17, 2017. View at Google Scholar
  10. A. A. E. Hagag, S. M. Amin, M. H. Emara, and S. E. Abo-Resha, “Gastric mucosal oxidative stress markers in children with Helicobacter pylori infection,” Infectious Disorders Drug Targets, 2017. View at Google Scholar
  11. C. A. Prauchner, “Oxidative stress in sepsis: pathophysiological implications justifying antioxidant co-therapy,” Burns, vol. 43, no. 3, pp. 471–485, 2016. View at Publisher · View at Google Scholar
  12. W. N. Beavers and E. P. Skaar, “Neutrophil-generated oxidative stress and protein damage in Staphylococcus aureus,” Pathogens and Disease, vol. 74, no. 6, 2016. View at Publisher · View at Google Scholar
  13. S. Bojic, J. Kotur-Stevuljevic, N. Kalezic et al., “Low paraoxonase 1 activity predicts mortality in surgical patients with sepsis,” Disease Markers, vol. 2014, Article ID 427378, 8 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. S. K. Mallipattu, J. C. He, and J. Uribarri, “Role of advanced glycation endproducts and potential therapeutic interventions in dialysis patients,” Seminars in Dialysis, vol. 25, no. 5, pp. 529–538, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Prasad and M. Mishra, “Do advanced glycation end products and its receptor play a role in pathophysiology of hypertension?” International Journal of Angiology, vol. 26, no. 1, pp. 1–11, 2017. View at Publisher · View at Google Scholar
  16. A. M. Schmidt, S. D. Yan, S. F. Yan, and D. M. Stern, “The biology of the receptor for advanced glycation end products and its ligands,” Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, vol. 1498, no. 2-3, pp. 99–111, 2000. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Prasad, “Low levels of serum soluble receptors for advanced glycation end products, biomarkers for disease state: myth or reality,” International Journal of Angiology, vol. 23, no. 1, pp. 11–16, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. G. S. El-Saeed, F. Fadel, M. F. Elshamaa et al., “Advanced glycation end products and soluble receptor as markers of oxidative stress in children on hemodialysis,” Renal Failure, vol. 37, no. 9, pp. 1452–1456, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Cai, T. Han, C. Nie et al., “Biomarkers of oxidation stress, inflammation, necrosis and apoptosis are associated with hepatitis B-related acute-on-chronic liver failure,” Clinics and Research in Hepatology and Gastroenterology, vol. 40, no. 1, pp. 41–50, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. R. Trotti, M. Carratelli, M. Barbieri et al., “Oxidative stress and a thrombophilic condition in alcoholics without severe liver disease,” Haematologica, vol. 86, no. 1, pp. 85–91, 2001. View at Google Scholar
  21. G. Cervato, P. Viani, R. Cazzola, and B. Cestaro, “A fluorescence method for the determination of plasma susceptibility to lipid peroxidation,” Clinical Biochemistry, vol. 32, no. 3, pp. 171–177, 1999. View at Publisher · View at Google Scholar · View at Scopus
  22. N. Khaper, S. Bryan, S. Dhingra et al., “Targeting the vicious inflammation-oxidative stress cycle for the management of heart failure,” Antioxidants & Redox Signaling, vol. 13, no. 7, pp. 1033–1049, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Valko, D. Leibfritz, J. Moncol, M. T. Cronin, M. Mazur, and J. Telser, “Free radicals and antioxidants in normal physiological functions and human disease,” The International Journal of Biochemistry & Cell Biology, vol. 39, no. 1, pp. 44–84, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Falcone, S. Bozzini, A. D'Angelo et al., “Plasma levels of soluble receptor for advanced glycation end products and coronary atherosclerosis: possible correlation with clinical presentation,” Disease Markers, vol. 35, no. 3, pp. 135–140, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Camera, E. Hopps, and G. Caimi, “Diabetic microangiopathy: physiopathological, clinical and therapeutic aspects,” Minerva Endocrinologica, vol. 32, no. 3, pp. 209–229, 2007. View at Google Scholar
  26. C. Di Filippo, M. Verza, L. Coppola, F. Rossi, M. D'Amico, and R. Marfella, “Insulin resistance and postprandial hyperglycemia the bad companions in natural history of diabetes: effects on health of vascular tree,” Current Diabetes Reviews, vol. 3, no. 4, pp. 268–273, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. J. E. Castelao and M. Gago-Dominguez, “Risk factors for cardiovascular disease in women: relationship to lipid peroxidation and oxidative stress,” Medical Hypotheses, vol. 71, no. 1, pp. 39–44, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. C. A. Guerrero and O. Acosta, “Inflammatory and oxidative stress in rotavirus infection,” World Journal of Virology, vol. 5, no. 2, pp. 38–62, 2016. View at Publisher · View at Google Scholar
  29. L. Cannizzaro, G. Rossoni, F. Savi et al., “Regulatory landscape of AGE-RAGE-oxidative stress axis and its modulation by PPARγ activation in high fructose diet-induced metabolic syndrome,” Nutrition & Metabolism, vol. 14, no. 1, p. 5, 2017. View at Publisher · View at Google Scholar
  30. M. Giannakou, K. Saltiki, E. Mantzou et al., “RAGE polymorphisms and oxidative stress levels in Hashimoto’s thyroiditis,” European Journal of Clinical Investigation, vol. 47, no. 5, pp. 341–347, 2017. View at Publisher · View at Google Scholar
  31. E. Devangelio, F. Santilli, G. Formoso et al., “Soluble RAGE in type 2 diabetes: association with oxidative stress,” Free Radical Biology & Medicine, vol. 43, no. 4, pp. 511–518, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. L. Massaccesi, M. M. Corsi, C. J. Baquero-Herrera et al., “Erythrocyte glycohydrolases in subjects with trisomy 21: could Down’s syndrome be a model of accelerated ageing?” Mechanisms of Ageing and Development, vol. 127, no. 4, pp. 324–331, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. G. Goi, L. Massaccesi, C. J. Baquero Herrera et al., “Oxidative stress in elderly chronic renal failure patients: effects of renal replacement therapies on cell membrane fluidity,” Journal of Nephrology, vol. 22, no. 5, pp. 630–636, 2009. View at Google Scholar
  34. A. Barassi, G. M. Colpi, G. Piediferro, G. Dogliotti, G. V. D'Eril, and M. M. Corsi, “Oxidative stress and antioxidant status in patients with erectile dysfunction,” The Journal of Sexual Medicine, vol. 6, no. 10, pp. 2820–2825, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. C. Falcone, E. Emanuele, A. D'Angelo et al., “Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 25, no. 5, pp. 1032–1037, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. J. B. Lindsey, J. A. de Lemos, F. Cipollone et al., “Association between circulating soluble receptor for advanced glycation end products and atherosclerosis: observations from the Dallas Heart Study,” Diabetes Care, vol. 32, no. 7, pp. 1218–1220, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. E. Selvin, M. K. Halushka, R. C. Hoogeveen, C. M. Ballantyne, J. Coresh, and B. C. Astor, “sRAGE and risk of diabetes, cardiovascular disease, and death,” Diabetes, vol. 62, no. 6, pp. 2116–2121, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. F. Santilli, L. Bucciarelli, D. Noto et al., “Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins,” Free Radical Biology & Medicine, vol. 43, no. 9, pp. 1255–1262, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. D. Geroldi, C. Falcone, E. Emanuele et al., “Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension,” Journal of Hypertension, vol. 23, no. 9, pp. 1725–1729, 2005. View at Publisher · View at Google Scholar
  40. S. H. Hoeboer, P. J. van der Geest, D. Nieboer, and A. B. Groeneveld, “The diagnostic accuracy of procalcitonin for bacteraemia: a systematic review and meta-analysis,” Clinical Microbiology and Infection, vol. 21, no. 5, pp. 474–481, 2015. View at Publisher · View at Google Scholar · View at Scopus